A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
for Uterine Fibroids
Drug: Relugolix
120 locations incl. Mobile
Sponsor: Sumitomo Pharma Switzerland GmbH
Sex: Female·Age: 18 - 50
Code: NCT05862272·Phase 3·Recruiting